A Study About How Different Doses of BI 1358894 Are Taken up in the Body and How Well They Are Tolerated in Healthy Japanese Men

NCT03875001 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Placebo
DRUG: Dose group 1 - 50 mg BI 1358894
DRUG: Dose group 2 - 100 mg BI 1358894
DRUG: Dose group 3 - 200 mg BI 1358894

Sponsor

Boehringer Ingelheim